Package 31722-001-02

{"route": ["ORAL"], "spl_id": "2b449c4a-56db-0d5f-e063-6394a90ad576", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0331722001601"], "unii": ["2T8Q726O95"], "rxcui": ["205328"], "spl_set_id": ["e90671c6-7fff-48f4-8898-29f02d049c8b"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "20 BLISTER PACK in 1 CARTON (31722-001-02)  / 10 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "31722-001-02", "marketing_start_date": "20190321"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (31722-001-60)", "package_ndc": "31722-001-60", "marketing_start_date": "20190321"}], "brand_name": "lamivudine", "product_id": "31722-001_2b449c4a-56db-0d5f-e063-6394a90ad576", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "31722-001", "generic_name": "lamivudine", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "lamivudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "100 mg/1"}], "application_number": "ANDA211306", "marketing_category": "ANDA", "marketing_start_date": "20190321", "listing_expiration_date": "20261231"}